Cargando…

Five-Year Trends in Potential Drug Interactions with Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation: An Australian-Wide Study

Background: Co-prescribing medications that can interact with direct-acting oral anticoagulants (DOACs) may decrease their safety and efficacy. The aim of this study was to examine the co-prescribing of such medications with DOACs using the Australian national general practice dataset, MedicineInsig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bezabhe, Woldesellassie M., Bereznicki, Luke R., Radford, Jan, Wimmer, Barbara C., Salahudeen, Mohammed S., Bindoff, Ivan, Garrahy, Edward, Peterson, Gregory M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694473/ https://www.ncbi.nlm.nih.gov/pubmed/33167560 http://dx.doi.org/10.3390/jcm9113568

Ejemplares similares

Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population‐Based Cohort Study
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2022)

Ten-Year Trends in the Use of Oral Anticoagulants in Australian General Practice Patients With Atrial Fibrillation
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2021)

Incidence of Osteoporosis in Primary Care Patients with Atrial Fibrillation Receiving Different Oral Anticoagulants
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2022)

Ten-Year Trends in Psychotropic Prescribing and Polypharmacy in Australian General Practice Patients with and without Dementia
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2023)

Improving Knowledge and Early Detection of Atrial Fibrillation through a Community-Based Opportunistic Screening Program: What’s Your Beat?
por: Jatau, Abubakar Ibrahim, et al.
Publicado: (2022)

Development and Validation of an Atrial Fibrillation Knowledge Assessment Tool (AFKAT)
por: Jatau Abubakar, Ibrahim, et al.
Publicado: (2020)

Oral Anticoagulant Discontinuation and Its Predictors in Patients with Atrial Fibrillation
por: Kefale, Adane Teshome, et al.
Publicado: (2022)

Medication Prescribing Quality in Australian Primary Care Patients with Chronic Kidney Disease
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2020)

Applying the Capability, Opportunity, and Motivation Behaviour Model (COM-B) to Guide the Development of Interventions to Improve Early Detection of Atrial Fibrillation
por: Jatau, Abubakar Ibrahim, et al.
Publicado: (2019)

Oral Anticoagulant Use in Patients with Atrial Fibrillation at Low Risk of Stroke and Associated Bleeding Complications
por: Kefale, Adane Teshome, et al.
Publicado: (2023)

Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2016)

Adherence to antiretroviral drug therapy in adult patients who are HIV-positive in Northwest Ethiopia: a study protocol
por: Bezabhe, Woldesellassie M, et al.
Publicado: (2013)

Comments: Absolute cardiovascular risk assessment for guiding antihypertensive prescribing in Australian primary care patients with hypertension
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2022)

Barriers and Facilitators of Adherence to Antiretroviral Drug Therapy and Retention in Care among Adult HIV-Positive Patients: A Qualitative Study from Ethiopia
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2014)

Ten-year trends in adverse drug reaction–related hospitalizations among people with dementia
por: Zaidi, Anum Saqib, et al.
Publicado: (2022)

Quality use of medicines in patients with chronic kidney disease
por: Castelino, Ronald L., et al.
Publicado: (2020)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Trends in Oral Anticoagulation Therapy Among Korean Patients With Atrial Fibrillation: The KORean Atrial Fibrillation Investigation
por: Shin, Hong-Won, et al.
Publicado: (2012)

Comparing Australian orthopaedic surgeons’ reported use of thromboprophylaxis following arthroplasty in 2012 and 2017
por: Mirkazemi, Corinne, et al.
Publicado: (2019)

Trend of Prevalence of Atrial Fibrillation and use of Oral Anticoagulation Therapy in Patients With Atrial Fibrillation in South Korea (2002–2013)
por: Son, Mi Kyoung, et al.
Publicado: (2018)

Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era
por: Sehrawat, Ojasav, et al.
Publicado: (2023)

Temporal trends in anticoagulation management for US active duty personnel with atrial fibrillation
por: Keithler, Andrea Nichole, et al.
Publicado: (2022)

Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation
por: Simon, Tracey G., et al.
Publicado: (2023)

Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes
por: Bezabih, Yihienew M., et al.
Publicado: (2021)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020
por: Navar, Ann Marie, et al.
Publicado: (2022)

Prescribers’ perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation
por: Generalova, Daria, et al.
Publicado: (2020)

Adherence with direct oral anticoagulants in patients with atrial fibrillation: Trends, risk factors, and outcomes
por: Arbel, Anat, et al.
Publicado: (2021)

Temporal Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients between 2004 and 2019
por: Gorczyca-Głowacka, Iwona, et al.
Publicado: (2022)

Trends of use and factors that determine the choice of oral anticoagulants in women and men with atrial fibrillation
por: Lenglet, Aurélie, et al.
Publicado: (2022)

Patients’ Perspectives on Commencing Oral Anticoagulants in Atrial Fibrillation: An Exploratory Qualitative Descriptive Study
por: Gebreyohannes, Eyob Alemayehu, et al.
Publicado: (2023)

Factors associated with first-line antiretroviral treatment failure in adult HIV-positive patients: a case-control study from Ethiopia
por: Bezabih, Yihienew Mequanint, et al.
Publicado: (2019)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Prescribing and Safety of Direct-Acting Oral Anticoagulants Compared to Warfarin in Patients with Atrial Fibrillation on Chronic Hemodialysis
por: Davis, Estella, et al.
Publicado: (2020)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

MRI Screening for Chronic Anticoagulation in Atrial Fibrillation
por: Fisher, Mark
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hmnbhbkktt4k6o13bafquid41k